Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Misonou, Y.; Shida, K.; Korekane, H.; Seki, Y.; Noura, S.; Ohue, M.; Miyamoto, Y.
    Comprehensive clinico-glycomic study of 16 colorectal cancer specimens: elucidation of aberrant glycosylation and its mechanistic causes in colorectal cancer cells (2009), J. Proteome Res., 8, 2990-3005.
    View publication on PubMed

Application

EC Number Application Comment Organism
3.2.1.123 medicine release of glycans from the ceramide moieties of glycosphingolipids by endoglycoceramidase II treatment in order to analyze structures of glycosphingolipids in normal human colorectal epithelial cells, and characteristic alterations of oligosaccharide structures in malignant transformation Rhodococcus sp.

Organism

EC Number Organism UniProt Comment Textmining
3.2.1.123 Rhodococcus sp.
-
-
-

Substrates and Products (Substrate)

EC Number Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
3.2.1.123 glycosphingolipid + H2O release of glycans from the ceramide moieties of glycosphingolipids by endoglycoceramidase II treatment in order to analyze structures of glycosphingolipids in normal human colorectal epithelial cells, and characteristic alterations of oligosaccharide structures in malignant transformation Rhodococcus sp. ?
-
 ?

Synonyms

EC Number Synonyms Comment Organism
3.2.1.123 endoglycoceramidase II
-
 Rhodococcus sp.